Oxford Silk Phage Technologies
OSPT is pioneering a unique antibacterial bioactive textile technology integrating bacteriophages, aimed at addressing the growing problem of surgical implant and wound infections. Founded in January 2020 in Oxford, England, the company combines expertise from clinicians, entrepreneurs, and scientists to develop natural antibacterial biomaterials that help people live more actively and longer. Their technology offers prophylactic use of phages in textiles, creating bioactive devices with long-lasting, cost-effective bactericidal activity to reduce infections and antibiotic use, ultimately contributing to combating antibiotic resistance.
Industries
Nr. of Employees
small (1-50)
Oxford Silk Phage Technologies
Products
Bioactive textile devices integrating bacteriophages
Textile-based medical devices produced by embedding bacteriophages into yarns to provide prophylactic antibacterial activity in implants and wound-care products.
Bioactive textile devices integrating bacteriophages
Textile-based medical devices produced by embedding bacteriophages into yarns to provide prophylactic antibacterial activity in implants and wound-care products.
Services
Partnerships and collaborative development
Collaborative engagement with external partners and investors to support development, testing and commercialization of phage-integrated textile devices.
Partnerships and collaborative development
Collaborative engagement with external partners and investors to support development, testing and commercialization of phage-integrated textile devices.
Expertise Areas
- Antibacterial biomaterials
- Phage-based prophylaxis and therapeutics
- Medical textile engineering
- Phage strain selection and adaptation
Key Technologies
- Bacteriophage embedding in textiles
- Yarn-level controlled bioloading
- Phage library selection and adaptation
- Biomaterial-based antimicrobial delivery